Global Bioburden Testing Market USD 907.4 million by 2024


@databridgemarketresearch


Global bioburden testing market is expected to reach USD 907.4 million by 2024 from USD 452.6 million in 2016, at a CAGR of 9.1% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Bioburden Testing Market, By Test Type (Aerobic, Anaerobic, Fungi, Spore), By Product Type (Instruments (PCR, Automated Microbial Identification Systems, Microscopes, Others), Consumables (Kits & Strips, Reagents, Others), By Technology (Microbial Filter Method, Advanced Colorimetric Method, Plate Count Method, Rapid Testing), By Application (Raw Material Testing, In-Process Testing, Medical Device Testing, Pharmaceutical & Cosmetic Testing, Food and Beverage Testing), By End-User (Pharmaceutical, Biotechnology, Industrial, Food & Beverages), By Geography (North America, Europe, Asia-Pacific, South America and Middle East Asia) – Industry Trends and Forecast to 2024

Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=bioburden-testing-market-industry-trends-and-forecast-to24

Bioburden Testing Market – Market Segmentation:

The global bioburden testing market is segmented on the basis of test type, product type, technology, application, end-user, and geography.

On the basis of test type the bioburden testing market is segmented into aerobic, anaerobic, fungi and spore count. The global bioburden testing market segment is further categorized on the basis of product type into instruments and consumable. The instrument market segment is sub-segment into automated microbial identification systems, PCR (polymerase chain reaction), microscopes. The consumables market segment is sub segmented into kits, reagents and other consumables.

The global bioburden testing market is also segmented on the basis of technology microbial filter method, advanced colorimetric method and plate count method. The plate count method and membrane filtration method can be used to analyze the number of microbes in sample; the sample is passing through a filter with a pore size of 0.45 micrometers or less. Oldest methods for bioburden testing plate count method, however is not used frequently on a great scale commercial basis due to its time consuming procedure. Advanced colorimetric method is at the moment the most capable and widely used bioburden testing technology. The gathering of colorimeter and computational capabilities has enabled advanced colorimetric methods to deliver swift results of quantifying bioburden.

On the basis of End User the market is segmented into Pharmaceutical, Biotechnology, Industrial, and Food & Beverage.

Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/bioburden-testing-market-industry-trends-and-forecast-to-2024/

Based on geography, the market is segmented into five geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa.

The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.

Some of the major players operating in this market are

  1. Charles
  2. Pacific Bio labs, Inc.
  3. Sigma-Aldrich Corporation
  4. SGS S.A.
  5. WuXi PharmaTech Inc.
  6. Becton
  7. Dickinson and Company
  8. Merck & Co., Inc.
  9. Charles River Laboratories International Inc.
  10. North American Science Associates, Inc. (NAMSA)
  11. Nelson Laboratories, Inc.
  12. Dynatec Labs
  13. ATS Labs, Inc.

Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=bioburden-testing-market-industry-trends-and-forecast-to24

Table Of Content:

  1. INTRODUCTION

1.1. OVERVIEW OF THE GLOBAL BIOBURDEN TESTING MARKET

1.2. MARKET SEGMENTATION & COVERAGE

1.2.1. CURRENCY AND PRICING

1.2.2. LIMITATION

1.2.3. STAKEHOLDERS

  1. RESEARCH METHODOLOGY

2.1. KEY TAKEAWAYS

2.2. ARRIVING AT THE GLOBAL BIOBURDEN TESTING MARKET

2.2.1. MARKET CRACKDOWN APPROACH

2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3. DATA TRIANGULATION

2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5. PRODUCT PIPELINE ANALYSIS

2.2.6. PORTER’S FIVE FORCES MATRIX

2.4. GLOBAL BIOBURDEN TESTING MARKET: RESEARCH SNAPSHOT

2.5. ASSUMPTIONS

  1. MARKET LANDSCAPE SUMMARY
  2. PREMIUM INSIGHTS

4.1. OVERVIEW

4.2. GLOBAL BIOBURDEN TESTING MARKET: KEY PRIMARY INSIGHTS

4.3. MARKET OVERVIEW

4.3.1. DRIVERS

4.3.1.1. VARYING TRENDS IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES

4.3.1.2. INCREASING MEDICAL DEVICE USAGE

4.3.1.3. MARKET AWARENESS

4.3.1.4. TREND TOWARDS FOOD SAFETY

4.3.1.5. STRONG R&D INVESTMENTS IN LIFE SCIENCE

4.3.2. RESTRAINTS

4.3.3. OPPURTUNITIES

4.3.4. THREATS

4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

  1. GLOBAL BIOBURDEN TESTING MARKET, BY TYPE

5.1. OVERVIEW

5.2. BIOBURDEN TESTING MARKET, BY TEST TYPE

5.2.1. AEROBIC

5.2.2. ANAEROBIC

5.2.3. FUNGI

5.2.4. SPORE COUNT

5.3. BIOBURDEN TESTING MARKET, BY PRODUCT TYPE

5.3.1. INSTRUMENTS

5.3.1.1. AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS

5.3.1.2. PCR (POLYMERASE CHAIN REACTION)

5.3.1.3. MICROSCOPES

5.3.2. CONSUMABLES

5.3.2.1. KITS

5.3.2.2. REAGENTS

5.3.2.3. OTHER CONSUMABLES

  1. GLOBAL BIOBURDEN TESTING MARKET, BY TECHNOLOGY

6.1. OVERVIEW

6.2. MICROBIAL FILTER METHOD

6.3. ADVANCED COLOMETRIC METHOD

6.4. PLATE COUNT METHOD

  1. GLOBAL BIOBURDEN TESTING MARKET, BY APPLICATION

7.1. OVERVIEW

7.2. RAW MATERIAL TESTING

7.3. IN PROCESS TESTING

7.4. MEDICAL DEVICE TESTING

7.5. PHARMACEUTICAL & COSMETIC TESTING

7.6. FOOD & BEVERAGE TESTING

  1. GLOBAL BIOBURDEN TESTING MARKET, BY END USER

8.1. OVERVIEW

8.2. PHARMACEUTICAL

8.3. BIOTECHNOLOGY

8.4. INDUSTRIAL

8.5. FOOD & BECERAGE

  1. GLOBAL BIOBURDEN TESTING MARKET, BY GEOGRAPHY

9.1. COUNTRYWISE BIOBURDEN TESTING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

9.1.1. NORTH AMERICA

9.1.1.1. U.S.

9.1.1.2. CANADA

9.1.1.3. MEXICO

9.1.2. EUROPE

9.1.2.1. GERMANY

9.1.2.2. FRANCE

9.1.2.3. U.K.

9.1.2.4. ITALY

9.1.2.5. SPAIN

9.1.2.6. RUSSIA

9.1.2.7. TURKEY

9.1.2.8. BELGIUM

9.1.2.9. NETHERLANDS

9.1.2.10. SWITZERLAND

9.1.2.11. REST OF EUROPE

9.1.3. ASIA-PACIFIC (APAC)

9.1.3.1. JAPAN

9.1.3.2. CHINA

9.1.3.3. SOUTH KOREA

9.1.3.4. INDIA

9.1.3.5. AUSTRALIA

9.1.3.6. SINGAPORE

9.1.3.7. THAILAND

9.1.3.8. MALAYSIA

9.1.3.9. INDONESIA

9.1.3.10. PHILIPPINES

9.1.3.11. REST OF APAC

9.1.4. LATIN AMERICA

9.1.4.1. BRAZIL

9.1.4.2. REST OF LATIN AMERICA

9.1.5. MIDDLE EAST AND AFRICA

9.1.5.1. SOUTH AFRICA

9.1.5.2. REST OF MIDDLE EAST AND AFRICA

9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

  1. GLOBAL BIOBURDEN TESTING MARKET: COMPETITIVE LANDSCAPE

10.1. GLOBAL BIOBURDEN TESTING MARKET: COMPANY SHARE ANALYSIS

10.2. U.S. BIOBURDEN TESTING MARKET: COMPANY SHARE ANALYSIS

10.3. EUROPE BIOBURDEN TESTING MARKET: COMPANY SHARE ANALYSIS

10.4. APAC BIOBURDEN TESTING MARKET: COMPANY SHARE ANALYSIS

10.5. SOUTH AMERICA BIOBURDEN TESTING MARKET: COMPANY SHARE ANALYSIS

10.6. MEA BIOBURDEN TESTING MARKET: COMPANY SHARE ANALYSIS

10.7. MERGERS & ACQUISITIONS

10.8. NEW PRODUCT DEVELOPMENT & APPROVALS

10.9. EXPANSIONS

10.10. REGULATORY CHANGES

10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

  1. GLOBAL BIOBURDEN TESTING MARKET MARKET: COMPANY PROFILES

11.1. WUXI PHARMA TECH INC.

11.1.1   COMPANY OVERVIEW

11.1.2   SWOT ANALYSIS

11.1.3   REVENUE ANALYSIS

11.1.4   PRODUCT PORTFOLIO

11.1.5   RECENT DEVELOPEMENTS

11.1.6   DATA BRIDGE ANALYSIS

11.2. CHARLES

11.2.1. COMPANY OVERVIEW

11.2.2   SWOT ANALYSIS

11.2.3   REVENUE ANALYSIS

11.2.4   PRODUCT PORTFOLIO

11.2.5   RECENT DEVELOPEMENTS

11.2.6   DATA BRIDGE ANALYSIS

11.3. PACIFIC BIO LABS INC.

11.3.1. COMPANY OVERVIEW

11.3.2. SWOT ANALYSIS

11.3.3. REVENUE ANALYSIS

11.3.4. PRODUCT PORTFOLIO

11.3.5. RECENT DEVELOPEMENTS

11.3.6. DATA BRIDGE ANALYSIS

11.4. SIGMA-ALDRICH CORPORATION

11.4.1   COMPANY OVERVIEW

11.4.2   SWOT ANALYSIS

11.4.3   REVENUE ANALYSIS

11.4.4   PRODUCT PORTFOLIO

11.4.5   RECENT DEVELOPEMENTS

11.4.6   DATA BRIDGE ANALYSIS

11.5. SGSS.A.

11.5.1   COMPANY OVERVIEW

11.5.2   SWOT ANALYSIS

11.5.3   REVENUE ANALYSIS

11.5.4   PRODUCT PORTFOLIO

11.5.5   RECENT DEVELOPEMENTS

11.5.6   DATA BRIDGE ANALYSIS

11.6. BECTON, DICKINSON AND COMPANY

11.6.1   COMPANY OVERVIEW

11.6.2   SWOT ANALYSIS

11.6.3   REVENUE ANALYSIS

11.6.4   PRODUCT PORTFOLIO

11.6.5   RECENT DEVELOPEMENTS

11.6.6   DATA BRIDGE ANALYSIS

11.7. MERCK & CO. INC.

11.7.1   COMPANY OVERVIEW

11.7.2   SWOT ANALYSIS

11.7.3   REVENUE ANALYSIS

11.7.4   PRODUCT PORTFOLIO

11.7.5   RECENT DEVELOPEMENTS

11.7.6   DATA BRIDGE ANALYSIS

11.8. CHARLES RIVER LABORATORIES INTERNATIONAL INC.

11.8.1   COMPANY OVERVIEW

11.8.2   SWOT ANALYSIS

11.8.3   REVENUE ANALYSIS

11.8.4   PRODUCT PORTFOLIO

11.8.5   RECENT DEVELOPEMENTS

11.8.6   DATA BRIDGE ANALYSIS

11.9. NORTH AMERICAN SCIENCE ASSOCIATES, INC.

11.9.1   COMPANY OVERVIEW

11.9.2   SWOT ANALYSIS

11.9.3   REVENUE ANALYSIS

11.9.4   PRODUCT PORTFOLIO

11.9.5   RECENT DEVELOPEMENTS

11.9.6   DATA BRIDGE ANALYSIS

11.10    NELSON LABORATORIES, INC.

11.10.1   COMPANY OVERVIEW

11.10.2   SWOT ANALYSIS

11.10.3   REVENUE ANALYSIS

11.10.4   PRODUCT PORTFOLIO

11.10.5   RECENT DEVELOPEMENTS

11.10.6   DATA BRIDGE ANALYSIS

11.11. DYNATEC LABS

11.11.1   COMPANY OVERVIEW

11.11.2   SWOT ANALYSIS

11.11.3   REVENUE ANALYSIS

11.11.4   PRODUCT PORTFOLIO

11.11.5   RECENT DEVELOPEMENTS

11.11.6   DATA BRIDGE ANALYSIS

11.12. ATS LABS, INC.

11.12.1   COMPANY OVERVIEW

11.12.2   SWOT ANALYSIS

11.12.3   REVENUE ANALYSIS

11.12.4   PRODUCT PORTFOLIO

11.12.5   RECENT DEVELOPEMENTS

11.12.6   DATA BRIDGE ANALYSIS

  1. APPENDIX

12.1. EPIDEMIOLOGY DATA

12.2. A GLIMSE OF DATA BRIDGE MARKET RESEARCH FACTBOOK

  1. ABOUT DATA BRIDGE MARKET RESEARCH

Related Report

Global Hemostats Market- Trends and Forecast to 2024

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/medical-devices/general-surgery-medical-devices/global-hemostats-market-trends-forecast-2024/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog http://databridgemarketresearch.com/blog/

Economy News